1[1]Snowden JA, Habbah EE, Donell J, et al. Resolution of longstanding systemic lupus erythematosus after transplantation for non-Hodgkins lymphoma. A case report. Bone Marrow Transplant, 1996,17:70.
2[2]Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI:a disease activity index for lupus patients. Arthritis Rheum, 1992, 35:630-640.
3[3]Tynadall A,Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease:a consensus report written on behalf of the European league against Rheumatism(EULAR) and the European Group for Blood and Marrow Transplantation(EBMT). Bone Marrow Transplant, 1997, 19:643-645.
4[4]Euler HH, Marmont AM, Bacigalupo A, et al. Early recurrence or persistence of autoimmune disease after unmanipulated autologous stem cell transplantation.Blood,1996,88:3621-3625.
5[5]Musso M, Porretto F. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease. Am J Hematl, 2001,66:75-79.
6[6]Traynor A, BURT RK. Haematopoietic stem cell transplantation for active systemic lupus erythematosus. Rheumatology (Oxford), 1998,38:767-772.
7[7]Fassas A, Anagnostostopoulos A, Kazis A,et al.Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis:first results of a pilot study. Bone Marrow Transplant, 1997, 20: 631-638.
8[8]Tyndall A, Fassas A, Passweg J,et al.Autologous haematopoitic stem cell transplants for autoimmune disease-feasibility and transplant-related mortality. Bone Marrow Transplantation,1999,(24):729-734.
